Strategic intelligence for the radiation healthcare

Bringing value to businesses and investors!

Over 3,300 pages of unrivaled intelligence covering

Nuclear Medicine

Cyclotrons

Proton Therapy

Brachytherapy

To obtain a detailed table of contents and sample pages

send an e-mail with your contact details at peg@medraysintell.com

Nuclear Medicine

Nuclear Medicine Report & Directory Edition 2019

A new set of three reports (some 2,300 pages) aiming at providing an exhaustive review of the global nuclear medicine landscape, thru an exhaustive description of more than 670 products, together with a comprehensive profile of nearly 280 companies around the world and with over 1,500 bibliographical references and their Web links.

MEDraysintell Nuclear Medicine (Part 1) - Marketed Radiopharmaceuticals
a complete document reviewing the market dynamics on a global basis, along with an exhaustive description and analysis of radionuclides and marketed radiopharmaceuticals, including the comprehensive profiles of companies active in nuclear medicine around the world.

MEDraysintell Nuclear Medicine (Part 2) - Clinical Radiopharmaceuticals
a comprehensive document providing an exhaustive description and analysis of radiopharmaceuticals presently under clinical development, i.e. for which clinical data are available, completed with the detailed profiles of all companies developing these products around the world.

MEDraysintell Nuclear Medicine (Part 3) - Early Stage Radiopharmaceuticals
a document providing a detailed description of selected radiopharmaceuticals under preclinical/early stage development, as well as a comprehensive profiles of all companies developing these new tracers and drugs.

More details and sample pages available upon request at peg@medraysintell.com

Cyclotrons

Cyclotrons used in Nuclear Medicine Report & Directory
 Edition 2020


MEDraysintell plans to publish a second edition of the Cyclotrons Report and Directory. This new Edition 2020 will be the result of a comprehensive collection of data over the past year that allowed MEDraysintell to identify almost 1,500 cyclotrons installed worldwide dedicated to the production of medical radionuclides (for nuclear medicine - radiopharmaceuticals).

This new report will provide an extensive review of all cyclotrons around the world with an exhaustive profile of the companies active in this market.

Expected to be released in March 2020

Proton Therapy

Proton Therapy World Market Report & Directory, Edition 2019

This sixth edition of the renowned World Proton Therapy report features in a 350-page document a comprehensive review of the world market dynamics with an analysis of both past evolutions and future trends to the year 2030, and a detailed profile of 29 promoters, manufacturers or developers of proton and carbon therapy equipment with a directory of all PT facilities that are expected to become operational by 2023.

Click the image to download a short presentation

Brachytherapy

Brachytherapy Market Report & Directory, Edition 2016

Second edition of the most comprehensive evaluation report and directory of brachytherapy, written by experts.This 340-page document provides a complete description of the radionuclides and devices used in brachytherapy, and a detailed profile of 62 companies and institutions active in this field around the world.

Click the image to download the information sheet

Transport and Handling of Radioisotopes

Report & Directory

MEDraysintell plans to publish a new report and directory covering the transport and handling of radioactive isotopes used in nuclear medicine. This document will cover the transport, packaging, handling and warehousing of radioactive isotopes, as well as reviewing the international and national regulations and security issues.
This new report will also review the training and specific competences needed in human resources within companies active in the transport of radioactive materials.

Furthermore, it will include a directory with an exhaustive profile of the several dozen of companies active in transport and handling of radioactive isotopes in the USA and Europe.

Expected to be released in 2021

Download our new flyer February 2019

MEDraysintell supports the initiative of Chris Behrenbruch (CEO at Telix Pharmaceuticals), who will participate at the 2019 SHITBOX RALLY, driving 5,150 km across the Australian desert from Perth to Sydney to raise funds for cancer research.
Click HERE for more details

© Copyright 2020  MEDraysintell

Contact
Paul-Emmanuel GOETHALS
Louvain-la-Neuve, Belgium
Phone: +32 491 080 968
peg@medraysintell.com